DR. GREGORY ALLEN ELDER, M.D.
Neurology in Bronx, NY
License number
New York 151302-1
Category
Neurology
Type
Neurology
Address
Address
2
130 WEST Kingsbridge Road (3F22), Bronx, NY 10468
182 E 95Th St, New York, NY 10128
182 E 95Th St, New York, NY 10128
Phone
(718) 584-9000
Personal information
See more information about GREGORY ALLEN ELDER at radaris.comName
Address
Phone
5719 Kings Hwy, Brooklyn, NY 11203
6 Elliot Ave, Dix Hills, NY 11746
182 E 95Th St APT 17J, New York, NY 10128
941 Kahle St, Bohemia, NY 11716
375 End Ave, New York, NY 10280
Professional information
Gregory Allen Elder, Bronx NY
Specialties:
Neurologist
Address:
130 W Kingsbridge Rd, Bronx, NY 10468
Board certifications:
American Board of Psychiatry and Neurology Certification in Neurology (Psychiatry and Neurology)
Dr. Gregory A Elder, Bronx NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
James J Peters VA Neurology
130 W Kingsbridge Rd SUITE 3E16, Bronx 10468
(718) 584-9000 (Phone)
130 W Kingsbridge Rd SUITE 3E16, Bronx 10468
(718) 584-9000 (Phone)
Certifications:
Neurology, 1986
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1980
Loyola University of Chicago / Stritch School of Medicine
Graduated: 1980
Genetically Engineered Animals Containing Null Mutations In The Neurofilament Genes
US Patent:
2002015, Oct 24, 2002
Filed:
Jun 22, 1999
Appl. No.:
09/338033
Inventors:
ROBERT A. LAZZARINI - NEW YORK NY, US
GREGORY ELDER - NEW YORK NY, US
GREGORY ELDER - NEW YORK NY, US
International Classification:
A01K067/027, A01K067/033
US Classification:
800/003000, 800/012000, 800/013000, 800/014000, 800/018000, 800/021000, 800/024000, 800/025000
Abstract:
The present invention provides for genetically engineered non-human animals, including but not limited to mice, which lack one or more endogenous neurofilament gene. Human neurofilament genes may be introduced into such genetically non-human animals (referred to hereafter as “knockout animals”) to produce improved models of the physiology of human neurofilament proteins which may be used to study human neurofilament-associated neurodegenerative conditions.